TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
4,264
|
1,895
|
316 |
| Financial expenses |
765
|
942
|
1,268 |
| Earnings before taxes |
-8,909
|
-14,166
|
-15,200 |
| EBITDA |
-6,971
|
-11,793
|
-12,004 |
| Total assets |
8,690
|
9,987
|
14,501 |
| Current assets |
5,046
|
4,835
|
7,897 |
| Current liabilities |
4,806
|
2,578
|
5,151 |
| Equity capital |
3,884
|
7,409
|
9,350 |
| - share capital |
7,580
|
6,024
|
4,014 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
44.7%
|
74.2%
|
64.5% |
| Turnover per employee |
711
|
316
|
53 |
| Profit as a percentage of turnover |
-208.9%
|
-747.5%
|
-4810.1% |
| Return on assets (ROA) |
-93.7%
|
-132.4%
|
-96.1% |
| Current ratio |
105.0%
|
187.5%
|
153.3% |
| Return on equity (ROE) |
-229.4%
|
-191.2%
|
-162.6% |
| Change turnover |
2,432
|
1,578
|
283 |
| Change turnover % |
133%
|
497%
|
865% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.